Respiratory Paralysis: Clinical Trials

2 trials for Respiratory Paralysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Respiratory Paralysis: new trials by email Literature Review of Respiratory Paralysis trials Research Report on Respiratory Paralysis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Diaphragmatic Paralysis Comparison Between Local Anesthetic Volumen Doses After Interscalene Block
Interscalene brachial plexus block, Levobupivacaine Hydrochloride 2.5 MG/ML - Diaphragmatic Paralysis, Brachial Plexus Block
Phase 3CompletedInstituto de Investigación Sanitaria Aragón482020-02-112022-08-12
Interscalene Block and Dysfunction Diaphragmatic
Ropivacaine 0.5% Injectable Solution, Ropivacaine 0.1% Injectable Solution - Diaphragmatic Paralysis
Phase 3CompletedUniversity Hospital, Lille602019-10-292026-06-11

Narrower conditions

Pain, Postoperative (1)  ·  Respiratory Aspiration (1)

Broader conditions

Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Paralysis (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiration Disorders (2)  ·  Respiratory Insufficiency (2)  ·  Respiratory Tract Diseases (2)  ·  Signs and Symptoms (2)  ·  Pain (1)  ·  Postoperative Complications (1)

Interventions

Levobupivacaine (1)  ·  Ropivacaine (1)

Sponsors

Instituto de Investigación Sanitaria Aragón (1)  ·  University Hospital, Lille (1)

Countries

France (1)  ·  Spain (1)

Results publications

PMID 33874993, PMID 42244823

NIH funding

2019 (1)